# Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension

> **NCT01093807** · PHASE2 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 1039 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Placebo
- **DRUG:** Lercanidipine
- **DRUG:** Lercanidipine
- **DRUG:** Enalapril
- **DRUG:** Enalapril
- **DRUG:** Lercanidipine + Enalapril
- **DRUG:** Lercanidipine + Enalapril
- **DRUG:** Lercanidipine + Enalapril
- **DRUG:** Lercanidipine + Enalapril

## Key facts

- **NCT ID:** NCT01093807
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 1039 (ACTUAL)
- **Last updated:** 2011-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093807, "Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01093807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*